BioSyent Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | BioSyent Inc.

BioSyent Inc. | Mutual Funds

Mutual Funds that own BioSyent Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Grandeur Peak International Opportunities Fund

345,600

2.38%

-28,400

0.3%

04/30/2018

Grandeur Peak Global Opportunities Fund

233,500

1.61%

-5,200

0.22%

04/30/2018

Manulife Canadian Focused Fund

179,404

1.24%

0.17%

12/31/2017

Cambridge Pure Canadian Equity Fund

114,600

0.79%

114,600

0.25%

06/30/2017

Grandeur Peak Global Reach Fund

111,100

0.77%

-2,000

0.22%

04/30/2018

Fidelity Small Cap Stock Fund

66,591

0.46%

66,591

0.03%

04/30/2018

37,893

0.26%

-4,100

0.68%

04/30/2018

16,086

0.11%

07/31/2018

Marquis Institutional Canadian Equity Portfolio

13,041

0.09%

2,582

0.1%

12/31/2017

Manulife Canadian Focused Class

6,996

0.05%

0.11%

04/30/2018

About BioSyent

View Profile

Address	170 Attwell Drive Toronto Ontario M9W 5Z5 Canada
Employees	-
Website	http://www.biosyent.com
Updated	07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.